LV10490A - DNS seciba kas kode proteinus ar HUSI-tipa inhibitoru biologisko aktivitati mineto proteinu iegusanas biotehnologiskais panemiens farmaceitiskas kompozicijas kas satur minetos proteinus - Google Patents

DNS seciba kas kode proteinus ar HUSI-tipa inhibitoru biologisko aktivitati mineto proteinu iegusanas biotehnologiskais panemiens farmaceitiskas kompozicijas kas satur minetos proteinus

Info

Publication number
LV10490A
LV10490A LV930376A LV930376A LV10490A LV 10490 A LV10490 A LV 10490A LV 930376 A LV930376 A LV 930376A LV 930376 A LV930376 A LV 930376A LV 10490 A LV10490 A LV 10490A
Authority
LV
Latvia
Prior art keywords
proteins
husi
biological activity
pharmaceutical compositions
compositions containing
Prior art date
Application number
LV930376A
Other languages
English (en)
Other versions
LV10490B (en
Inventor
Regina Heinzel
Heribert Appelhans
Hans-Guenther Gassen
Werner Machleidt
Ursula Seemueller
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of LV10490A publication Critical patent/LV10490A/lv
Publication of LV10490B publication Critical patent/LV10490B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
LVP-93-376A 1986-01-10 1993-05-18 Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins LV10490B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863600571 DE3600571A1 (de) 1986-01-10 1986-01-10 Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
LV10490A true LV10490A (lv) 1995-02-20
LV10490B LV10490B (en) 1995-10-20

Family

ID=6291649

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-376A LV10490B (en) 1986-01-10 1993-05-18 Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins

Country Status (16)

Country Link
US (1) US4845076A (lv)
EP (1) EP0232523B1 (lv)
JP (2) JP2533869B2 (lv)
AT (1) ATE88500T1 (lv)
AU (1) AU604003B2 (lv)
CA (1) CA1326216C (lv)
DE (2) DE3600571A1 (lv)
DK (1) DK11187A (lv)
ES (1) ES2054612T3 (lv)
HU (1) HU204888B (lv)
IE (1) IE61526B1 (lv)
IL (1) IL81221A0 (lv)
LT (1) LTIP1753A (lv)
LV (1) LV10490B (lv)
PT (1) PT84089B (lv)
ZA (1) ZA87141B (lv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US6132990A (en) * 1984-12-06 2000-10-17 Amgen Boulder Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
US5851983A (en) * 1987-12-28 1998-12-22 Teijin Limited Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE3841873A1 (de) * 1988-12-13 1990-06-21 Gruenenthal Gmbh Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
US6869925B1 (en) * 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
WO1995025539A1 (fr) * 1994-03-23 1995-09-28 Tokyo Tanabe Company Limited Nouveau remede contre les maladies virales des voies respiratoires
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase
US6544740B1 (en) 1999-07-01 2003-04-08 Reprogen, Inc. Treatment of endometriosis with antileukoprotease
EP1400247A1 (en) * 1999-07-01 2004-03-24 Reprogen, Inc. Treatment of endometriosis with antileukoprotease
US7247704B2 (en) * 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
WO2003018620A2 (en) * 2001-08-27 2003-03-06 Les Laboratoires Aeterna Inc. Serine protease inhibitor and processes for the preparation thereof
GB2532488B (en) * 2014-11-21 2019-07-31 Univ Of The Western Cape Use of AMP1 or AMP8 to diagnose HIV infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95223A (en) * 1984-12-06 1992-08-18 Synergen Biolog Inc Dna sequence for production of serine protease inhibitors
DE3587526T3 (de) * 1984-12-06 2002-08-08 Amgen Inc.(N.D.Ges D. Staates Delaware), Thousand Oaks Serinproteaseinhibitoren und isolierungsverfahren dazu.
JPS62501291A (ja) * 1984-12-06 1987-05-21 サイナ−ゲン　バイオロジカルズ，インコ−ポレ−テツド 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物

Also Published As

Publication number Publication date
ES2054612T3 (es) 1994-08-16
PT84089A (en) 1987-02-01
CA1326216C (en) 1994-01-18
LV10490B (en) 1995-10-20
JP2659525B2 (ja) 1997-09-30
IE61526B1 (en) 1994-11-16
EP0232523A2 (de) 1987-08-19
JPH07300500A (ja) 1995-11-14
US4845076A (en) 1989-07-04
IE870055L (en) 1987-07-10
ZA87141B (en) 1987-08-26
HUT43106A (en) 1987-09-28
PT84089B (pt) 1989-02-28
DK11187A (da) 1987-07-11
AU6745287A (en) 1987-07-16
EP0232523A3 (en) 1988-12-07
LTIP1753A (en) 1995-07-25
IL81221A0 (en) 1987-08-31
JPS62259591A (ja) 1987-11-11
AU604003B2 (en) 1990-12-06
JP2533869B2 (ja) 1996-09-11
DE3600571A1 (de) 1987-08-06
EP0232523B1 (de) 1993-04-21
HU204888B (en) 1992-02-28
DK11187D0 (da) 1987-01-09
DE3688324D1 (de) 1993-05-27
ATE88500T1 (de) 1993-05-15

Similar Documents

Publication Publication Date Title
LV10490A (lv) DNS seciba kas kode proteinus ar HUSI-tipa inhibitoru biologisko aktivitati mineto proteinu iegusanas biotehnologiskais panemiens farmaceitiskas kompozicijas kas satur minetos proteinus
RU94046367A (ru) Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела
ATE113295T1 (de) Tumornekrosefaktor, verfahren zu seiner herstellung, denselben enthaltende zusammensetzungen, dafür kodierende dns und diese dns verwendendes testverfahren.
RU95115239A (ru) Аналог эритропоэтина
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
DE68926888D1 (de) Verfahren zur Herstellung von sekretierten Rezeptoranalogen
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DK0409472T3 (da) Knoglemorfogenetisk protein
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
GR3000944T3 (en) Pharmaceutical composition containing thymus extract fractions
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
AU613583B2 (en) Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
DE19781038T1 (de) Keratinozytenwachstumsfaktor-2-Produkte
ES2080060T3 (es) Proteinas que tienen actividad de union a interferon-gamma.
ATE87977T1 (de) Herstellung menschlichen somatomedins c.
Cho et al. Isolation of Sunflower Seed Protein and its Chemical Composition
ES531495A0 (es) Procedimiento para preparar un hidrolizado proteinico
RU94046405A (ru) Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок
IT1276765B1 (it) Gene del cromosoma x umano e proteina codificata da detto gene.
ATE55411T1 (de) Menschliches antithrombin iii, dns sequenzen dafuer, expressions- und klonierungsvektoren die solche sequenzen enthalten und damit transformierte zellkulturen, verfahren zur expression von menschlichem antithrombin iii und diese enthaltende pharmazeutische zusammensetzungen.